We are live on ! Find out more
LI

LRI Investments Portfolio holdings

AUM $1.24B
1-Year Est. Return 11.13%
This Fund
S&P 500
This Quarter Est. Return
+2.74%
1 Year Est. Return
+11.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$44.5M
Cap. Flow
+$71.8M
Cap. Flow %
5.87%
Top 10 Hldgs %
59.28%
Holding
1,372
New
107
Increased
266
Reduced
279
Closed
63

Top Buys

Rank Stock Value
1
ARES icon
Ares Management
ARES
+$43M
2
DCOR icon
Dimensional US Core Equity 1 ETF
DCOR
+$15.5M
3
DFAX icon
Dimensional World ex US Core Equity 2 ETF
DFAX
+$3.84M
4
DFAR icon
Dimensional US Real Estate ETF
DFAR
+$2.65M
5
DSTL icon
Distillate US Fundamental Stability & Value ETF
DSTL
+$2.28M

Top Sells

Rank Stock Value
1
JAVA icon
JPMorgan Active Value ETF
JAVA
+$930K
2
PAPI icon
Parametric Equity Premium Income ETF
PAPI
+$615K
3
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$610K
4
ARTY
iShares Future AI & Tech ETF
ARTY
+$399K
5
NVO
Novo Nordisk
NVO
+$366K

Sector Composition

Rank Sector Weight
1 Financials 36.13%
2 Technology 6.65%
3 Industrials 3.3%
4 Consumer Discretionary 2.17%
5 Healthcare 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VVX icon
526
V2X
VVX
$2.6B
$57.4K ﹤0.01%
+989
New +$52.9K
GMED icon
527
Globus Medical
GMED
$11.6B
$57.3K ﹤0.01%
+1,000
New +$57.6K
DOCS icon
528
Doximity
DOCS
$4.57B
$57.2K ﹤0.01%
782
– –
WST icon
529
West Pharmaceutical
WST
$24.8B
$57.2K ﹤0.01%
218
– –
UTG icon
530
Reaves Utility Income Fund
UTG
$3.61B
$57.1K ﹤0.01%
1,440
– –
UL icon
531
Unilever
UL
$135B
$57K ﹤0.01%
855
+69
+9% +$4.76K
TEVA icon
532
Teva Pharmaceuticals
TEVA
$42.1B
$56.8K ﹤0.01%
2,813
+2,000
+246% +$35.1K
BKR icon
533
Baker Hughes
BKR
$63.6B
$56.2K ﹤0.01%
1,154
+122
+12% +$5.38K
VRT icon
534
Vertiv
VRT
$104B
$56.1K ﹤0.01%
372
-94
-20% -$12.5K
AGCO icon
535
AGCO
AGCO
$7.06B
$55.9K ﹤0.01%
522
-6
-1% -$663
HIMS icon
536
Hims & Hers Health
HIMS
$7.35B
$55.1K ﹤0.01%
+971
New +$49.8K
CHE icon
537
Chemed
CHE
$7.18B
$54.7K ﹤0.01%
122
-47
-28% -$21.3K
RAL
538
Ralliant Corp
RAL
$7.68B
$54.7K ﹤0.01%
1,250
-3
-0.2% -$133
VO icon
539
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$54.3K ﹤0.01%
740
-8
-1% -$575
AGNC icon
540
AGNC Investment
AGNC
$12.8B
$53.8K ﹤0.01%
5,496
– –
HUM icon
541
Humana
HUM
$46.3B
$53.7K ﹤0.01%
206
+186
+930% +$48.9K
CP icon
542
Canadian Pacific Kansas City
CP
$79.6B
$53.6K ﹤0.01%
719
– –
EIX icon
543
Edison International
EIX
$26.1B
$53.2K ﹤0.01%
+963
New +$52K
GL icon
544
Globe Life
GL
$14.2B
$53K ﹤0.01%
371
-310
-46% -$42K
NDAQ icon
545
Nasdaq
NDAQ
$53.4B
$52.8K ﹤0.01%
597
-128
-18% -$11.9K
SHLD icon
546
Global X Defense Tech ETF
SHLD
$7.71B
$52.7K ﹤0.01%
750
– –
JLL icon
547
Jones Lang LaSalle
JLL
$16.4B
$52.5K ﹤0.01%
176
-65
-27% -$18.6K
CPB icon
548
Campbell Soup
CPB
$6.69B
$52.4K ﹤0.01%
1,660
-205
-11% -$6.63K
HLNE icon
549
Hamilton Lane
HLNE
$5.53B
$51.9K ﹤0.01%
385
+205
+114% +$30.9K
RGA icon
550
Reinsurance Group of America
RGA
$15.8B
$50.7K ﹤0.01%
264
+77
+41% +$14.7K
20 21
22
23 24

Similar funds

SPC
Stony Point Capital New York $1.24B AUM 32.69% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return
FFM
Fullerton Fund Management Singapore $1.25B AUM 76.88% 1-Year Est. Return
LMGAM
Liberty Mutual Group Asset Management Boston, Massachusetts $1.25B AUM 45.27% 1-Year Est. Return
LIA
Limestone Investment Advisors New York $1.25B AUM 25.43% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

LRI Investments's Q3 2025 Portfolio in Review

As of Q3 2025, LRI Investments held 1,372 positions worth $1.22B, up 3.8% from $1.18B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

LRI Investments deployed $71.8M of net new capital in Q3 2025, opening 107 new positions and adding to 266 existing holdings. Its largest new stake was Comerica: 1,450 shares worth $99.4K.

By sector, the portfolio is most concentrated in Financials at 36% of assets, down from 40% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JPMorgan Active Value ETF, an estimated $930K trimmed.

  • LRI Investments's largest Q3 2025 buy was Comerica: 1,450 shares worth $99.4K.
  • LRI Investments added most to Ares Management in Q3 2025, an estimated $43M increase.
  • LRI Investments's biggest Q3 2025 reduction was JPMorgan Active Value ETF, cutting an estimated $930K.
  • LRI Investments fully exited TPI Composites in Q3 2025, selling an estimated $255K.
  • LRI Investments's ten largest holdings make up 59% of its $1.22B portfolio in Q3 2025.
  • LRI Investments opened 107 new positions and closed 63 in Q3 2025.
  • LRI Investments's portfolio value rose 3.8% quarter-over-quarter to $1.22B.

Based on LRI Investments's 13F filing for Q3 2025, filed 3 Nov 2025.